A Systematic Review of Molecular Hydrogen Therapy in Cancer Management

Muhammad Nooraiman Zufayri Mohd Noor1, Adlin Sofea Alauddin1, Yin How Wong2

  • 1School of Health Sciences, Faculty of Medicine and Health, International Medical University, 57000 Kuala Lumpur, Malaysia.

Abstract

Insights

Molecular hydrogen (H2) shows promise as a cancer therapy, improving survival and reducing tumors. This adjunctive therapy offers benefits with fewer side effects than traditional treatments.

Area of Science:

  • Oncology
  • Biomedical Science

Background:

  • Cancer treatment faces challenges with current therapies causing severe side effects.
  • Molecular hydrogen (H2) exhibits anti-proliferative, anti-oxidative, pro-apoptotic, and anti-tumoural effects, making it a potential cancer therapy.

Approach:

  • A systematic review was conducted using Cochrane, PubMed, and Google Scholar.
  • Eligible studies published in English within the last 10 years were selected.

Key Points:

  • 27 articles were analyzed from an initial 677, revealing consistent outcomes across various H2 administration methods, study designs, and cancer types.
  • Molecular hydrogen demonstrated consistent positive results in cancer management.

Conclusions:

  • Molecular hydrogen (H2) shows significant therapeutic potential as both a standalone and adjuvant cancer therapy.
  • H2 therapy improved survival rates, quality of life, blood parameters, and reduced tumor size, warranting consideration as a complementary cancer treatment.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Hydrogen Bonds00:26

Hydrogen Bonds

Hydrogen bonds are weak attractions between atoms that have formed other chemical bonds. One of these atoms is electronegative, like oxygen, and has a partial negative charge. The other is a hydrogen atom that has bonded with another electronegative atom and has a partial positive charge.
Hydrogen Bonds Control the World!
Because hydrogen has very weak electronegativity when it binds with a strongly electronegative atom, such as oxygen or nitrogen, electrons in the bond are unequally shared....
121.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K